Flatten the Bureaucracy: Deregulation and Covid-19 Testing

19 Pages Posted: 10 Aug 2020

See all articles by Raymond March

Raymond March

North Dakota State University - Department of Agribusiness and Applied Economics; North Dakota State University - NDSU Center for the Study of Public Choice and Private Enterprise

Date Written: August 6, 2020

Abstract

Lockdown measures enacted across the US due to the Covid-19 pandemic have severely curtailed personal and economic liberty. Although a growing body of research estimates the benefits and costs of these restrictive measures, significantly less research examines the role of deregulation in expanding healthcare capacity. This paper examines the impact of the FDA and CDC's deregulation on Covid-19 testing. I find laboratories and test developers greatly expanded Covid-19 testing availability and expanded the variety of tests after deregulation occurred. My findings provide critical and timely implications for research in public health and pandemic response policy more broadly.

Keywords: Deregulation, Covid-19, Food and Drug Administration, Health Policy, Public Health

JEL Classification: I180, I110, I190

Suggested Citation

March, Raymond, Flatten the Bureaucracy: Deregulation and Covid-19 Testing (August 6, 2020). Available at SSRN: https://ssrn.com/abstract=3668493 or http://dx.doi.org/10.2139/ssrn.3668493

Raymond March (Contact Author)

North Dakota State University - Department of Agribusiness and Applied Economics ( email )

Fargo, ND 58105
United States

North Dakota State University - NDSU Center for the Study of Public Choice and Private Enterprise

811 2nd Ave N.
Fargo, ND 58102
United States

Do you want regular updates from SSRN on Twitter?

Paper statistics

Downloads
125
Abstract Views
1,488
rank
304,146
PlumX Metrics